Expressions of CD147, matrix metalloproteinase-9 in carotid atherosclerotic plaque and the interference effect of atorvastatin on them
高菊华, 高小平
Abstract
高菊华, 高小平
Abstract
Objective To investigate the expression of CD147 and matrix metalloproteinase-9 (MMP-9) in rabbit models of carotid atherosclerotic plaque and the interference effect of atorvastatin on their expressions. Methods Twenty-four New Zealand white male rabbits were randomly divided into group A (normal diet group, n=8), and group B (n=16). Group A was given normal diet for 16 weeks. The 16 rabbits in group B underwent balloon-induced endothelial injury in the right carotid artery, and thereafter, were fed with a high-cholesterol diet (1% cholesterol) for 12 weeks; then, these rabbits were divided into group C (the model control group), and group D (undergoing gastric perfusion of atorvastatin Russell's viper venom and histamine. The damaged carotid arteries in all the groups were collected to undergo pathological examination. The protein expressions of MMP-9 and CD147, and the level of macrophages were detected by immunohistochemical analysis, and the mRNA expressions of MMP-9 and CD147 were evaluated by reverse-transcription PCR. Results In group C, it was found that plaque disruption and thrombosis occurred in 4 out of the 6 rabbits after triggering, while in group D, only 1 rabbit demonstrated plaque disruption and thrombosis; however, rabbits in the normal diet group did not have plaque disruption and thrombosis. Group D showed significantly decreased level of macrophage (16.22±2.61), decreased percentages of positive staining area of protein expression levels of MMP-9 (11.11±1.87) and CD147 (14.22±1.63) as compared with group C (33.62±3.82, 21.18±4.75 and 29.54±3.03, respectively) (P〈0.05). Significant difference on the mRNA expression levels of CD147 and MMP-9 was noted between group C (0.939±0.105, 0.335±0.069, respectively) and group D (0.4256±0.112, 0.135 ±0.067, respectively) (P〈0.05). The levels of the protein, mRNA expressions of CD 147 and MMP-9 were correlative positively by Pearson's correlation coefficient (r=0.669, 0.783, respectively, P=0.001, P=0.000). Conclusion The up-expression of CD147 and MMP-9 may be involved in the pathogenesis of vulnerable carotid atherosclerotic plaque and atorvastatin can stabilize the plaque possibly through inhibiting the CD 147, and MMP-9 expressions. Key words: Atherosclerosis CD147 Matrix metalloproteinase-9 Atorvastatin
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the expression of CD147 and matrix metalloproteinase-9 (MMP-9) in rabbit models of carotid atherosclerotic plaque and the interference effect of atorvastatin on their expressions. Methods Twenty-four New Zealand white male rabbits were randomly divided into group A (normal diet group, n=8), and group B (n=16). Group A was given normal diet for 16 weeks. The 16 rabbits in group B underwent balloon-induced endothelial injury in the right carotid artery, and thereafter, were fed with a high-cholesterol diet (1% cholesterol) for 12 weeks; then, these rabbits were divided into group C (the model control group), and group D (undergoing gastric perfusion of atorvastatin Russell's viper venom and histamine. The damaged carotid arteries in all the groups were collected to undergo pathological examination. The protein expressions of MMP-9 and CD147, and the level of macrophages were detected by immunohistochemical analysis, and the mRNA expressions of MMP-9 and CD147 were evaluated by reverse-transcription PCR. Results In group C, it was found that plaque disruption and thrombosis occurred in 4 out of the 6 rabbits after triggering, while in group D, only 1 rabbit demonstrated plaque disruption and thrombosis; however, rabbits in the normal diet group did not have plaque disruption and thrombosis. Group D showed significantly decreased level of macrophage (16.22±2.61), decreased percentages of positive staining area of protein expression levels of MMP-9 (11.11±1.87) and CD147 (14.22±1.63) as compared with group C (33.62±3.82, 21.18±4.75 and 29.54±3.03, respectively) (P〈0.05). Significant difference on the mRNA expression levels of CD147 and MMP-9 was noted between group C (0.939±0.105, 0.335±0.069, respectively) and group D (0.4256±0.112, 0.135 ±0.067, respectively) (P〈0.05). The levels of the protein, mRNA expressions of CD 147 and MMP-9 were correlative positively by Pearson's correlation coefficient (r=0.669, 0.783, respectively, P=0.001, P=0.000). Conclusion The up-expression of CD147 and MMP-9 may be involved in the pathogenesis of vulnerable carotid atherosclerotic plaque and atorvastatin can stabilize the plaque possibly through inhibiting the CD 147, and MMP-9 expressions. Key words: Atherosclerosis CD147 Matrix metalloproteinase-9 Atorvastatin
Key concepts: Atorvastatin, Thrombosis, Medicine, Internal medicine, Matrix metalloproteinase, H&E stain, Pathology, Immunohistochemistry